5:35 PM
 | 
Oct 30, 2012
 |  BC Extra  |  Company News

Takeda seeks cetilistat Japanese approval

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for cetilistat to treat obesity in patients...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >